GRI Reference Table

Global Reporting Frameworks

Pfizer continues to evaluate our approach to non-financial reporting, including reference to several existing, globally recognized external frameworks.

These include the Global Reporting Initiative (GRI), the Sustainability Accounting Standards Board (SASB) and the International Integrated Reporting Council (IIRC). We have relied on elements of each framework in developing this year's Annual Review while adhering to none in its entirety. We have included a GRI Reference Table in this Annual Review as a reference tool to help readers more readily locate relevant information across Pfizer's web-based resources.

We also take into account elements of other Environment, Social and Governance (ESG) indices and sustainability indicators, in particular the Access to Medicines Index and the United Nations (UN) Sustainable Development Goals (SDGs).

Download GRI Reference Table

GRI Table (PDF 0.5MB)

GRI Indicator Description Reference Alignment with the SDGs*
GRI 102: General Disclosures 2017
Organizational Profile
102-1 Name of the organization Pfizer Inc.  
102-2 Activities, brands, products, and services CEO Letter  
102-3 Location of headquarters New York, New York (U.S.)  
102-4 Location of operations Delivering Value through our Global Businesses  
102-5 Ownership and legal form Corporate and Shareholder Information  
102-6 Markets served Delivering Value through our Global Businesses  
102-7 Scale of the organization CEO Letter  
102-9 Supply chain Manufacturing and Supply Chain Excellence Goal 9
Goal 12
102-11 Precautionary Principle or approach Pfizer manages and reports on our risks and impacts in consideration of the precautionary principle.  
102-12 External initiatives Governance and Ethics  
102-13 Membership of associations Lobbying and Political Contributions  
102-14 Statement from senior decision-maker CEO Letter  
102-15 Key impacts, risks, and opportunities Governance and Ethics  
Ethics and Integrity
102-16 Values, principles, standards, and norms of behavior Pfizer Compliance Goal 16
102-17 Mechanisms for advice and concerns about ethics Governance and Ethics  
102-18 Governance structure Governance and Ethics  
102-19 Delegating authority Corporate Governance FAQs  
102-20 Executive-level responsibility for economic, environmental and social topics Environment, Health & Safety Goal 3
102-21 Consulting stakeholders on economic, environmental and social topics Stakeholder Engagement  
102-22 Composition of the highest governance body and its committees Board of Directors Goal 16
102-23 Chair of the highest governance body The Pfizer Board: Board Policies Goal 16
102-24 Nominating and selecting the highest governance body The Pfizer Board: Board Policies Goal 5
Goal 16
102-25 Conflicts of interest The Pfizer Board: Board Policies Goal 16
102-26 Role of highest governance body in setting purpose, values, and strategy The Pfizer Board: Board Policies  
102-27 Collective knowledge of highest governance body Board Committees and Charters  
102-28 Evaluating the highest governance body's performance Board Committees and Charters  
102-29 Identifying and managing economic, environmental and social impacts The Pfizer Board: Board Policies
Board Committees and Charters
Goal 16
102-31 Review of economic, environmental and social topics The Pfizer Board: Board Policies
Board Committees and Charters
102-32 Highest governance body's role in sustainability reporting About this Review
Board Committees and Charters
Stakeholder Engagement
102-40 List of stakeholder groups Stakeholder Engagement  
102-43 Approach to stakeholder engagement Stakeholder Engagement  
Reporting practice
102-45 Entities included in the consolidated financial statements About this Review  
102-46 Defining report content and topic Boundaries About this Review  
102-47 List of material topics About this Review  
102-49 Changes in reporting No changes in reporting since 2016 report  
102-50 Reporting period About this Review  
102-51 Date of most recent report March 12, 2018  
102-52 Reporting cycle We report on an annual basis  
102-53 Contact point for questions regarding the report Chris Gray, Senior Director, Corporate Responsibility  
102-55 GRI content index GRI Reference Table  
Material topics
GRI 103: Management Approach 2017
103-1 Explanation of the material topic and its Boundary About this Review  
103-2 The management approach and its components Product Stewardship  
103-3 Evaluation of the management approach Product Stewardship  
Economic Performance
201-1 Direct economic value generated and distributed Performance  
Indirect Economic Impacts
203-1 Infrastructure investments and services supported Individual Voices  
203-2 Significant indirect economic impacts Understanding the External Environment
Manufacturing & Supply Chain Excellence
Community Health
Access to Medicines

Goal 1
Goal 3
Goal 8
Goal 10
Procurement Practices
204-1 Proportion of spending on local suppliers Ethics and Compliance Goal 12
205-1 Operations assessed for risks related to corruption Pfizer Compliance Goal 16
303-1 Water withdrawal by source Performance Goal 6
305-1 Direct (Scope 1) GHG emissions Performance
Environment, Health & Safety
Environmental KPIs
Goal 13
305-2 Energy indirect (Scope 2) GHG emissions Performance
Environment, Health & Safety
Environmental KPIs
Goal 13
Effluents and Waste
306-2 Waste by type and disposal method Performance Goal 12
Supplier Environmental Assessment
308-2 Negative environmental impacts in the supply chain and actions taken Performance Goal 12
Occupational Health & Safety
403-2 Types of injury and rates of injury, occupational diseases, lost days, and absenteeism and number of work-related fatalities Environment, Health & Safety
Goal 3
Goal 8
Training and Education
404-1 Average hours of training per year per employee Culture Goal 4
Goal 5
Goal 8
404-2 Programs for upgrading employee skills and transition assistance programs Culture Goal 8
406-1 Incidents of discrimination and corrective actions taken Culture Goal 5
Goal 8
Goal 16
Human Rights Assessment
412-2 Employee training on human rights policies or procedures Human Rights Statement  
Local Communities
413-1 Operations with local community engagement, impact assessments and development programs Community Health Goal 3
Goal 4
Goal 5
Goal 6
Goal 7
Goal 17
Public Policy
415-1 Political contributions Corporate and Shareholder Information Goal 16
Customer Privacy
418-1 Substantiated complaints concerning breaches of customer privacy and losses of customer data How We Conduct Clinical Trials Goal 16

* Based on ‘SDG Compass: Linking the SDGs and GRI’, as available on the GRI website’s resource library. Click here to view.